Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6621643 | 0.95 | RECQL (0.47) | SLC22A1RECQLTSHRGLAHPGD | |
| Tetrahexylammonium SCHEMBL6618528 | 0.95 | RECQL (0.47) | SLC22A1RECQLTSHRGLAHPGD | |
| Tetrabuthylammonium SCHEMBL27774570 | 0.90 | SLC22A1 (0.55) | SLC22A1RECQLTSHRGLAHPGD | |
| Tetrabuthylammonium SCHEMBL991019 | 0.90 | SLC22A1 (0.55) | SLC22A1RECQLTSHRGLAHPGD | |
| SCHEMBL6619377 | 0.90 | DNM1 (0.52) | SLC22A1RECQLTSHRGLAHPGD | |
| Tetrapropylammonium SCHEMBL6619011 | 0.89 | CA2 (0.40) | SLC22A1RECQLTSHRGLAHPGD | |
| SCHEMBL6617390 | 0.84 | DNM1 (0.50) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL6616485 | 0.84 | SLC22A1 (0.56) | SLC22A1RECQLTSHRGLAHPGD | |
| Tetrahexylammonium SCHEMBL7662222 | 0.84 | SLC22A1 (0.56) | SLC22A1RECQLTSHRGLAHPGD | |
| Tetrabuthylammonium SCHEMBL24419 | 0.82 | SLC22A1 (0.60) | SLC22A1RECQLTSHRGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12139467-B2 | Methods of synthesizing cannabielsoin and analogs thereof | CANOPY GROWTH CORPORATION (CA) | 2024-11-12 | — | — | US | claimed |
| EP-4188915-A1 | METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF | Canopy Growth Corporation (CA) | 2023-06-07 | — | — | EP | claimed |
| US-20230146330-A1 | METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF | JGB COLLATERAL LLC | 2023-05-11 | — | — | US | claimed |
| WO-2022020944-A1 | METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF | CANOPY GROWTH CORPORATION (CA) | 2022-02-03 | — | — | WO | claimed |
| CN-111518154-B | Preparation method of 24-epibrassinol intermediate (22E, 24R) -3 alpha, 5-ring-5 alpha-ergosta-7, 22-diene-6-ketone | 郑州郑氏化工产品有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-111518154-A | Preparation method of 24-epibrassinol intermediate | 郑州郑氏化工产品有限公司 | 2020-08-11 | — | — | CN | claimed |
| EP-4695239-A1 | DISUBSTITUTED PYRIMIDINE COMPOUNDS FOR KETOHEXOKINASE INHIBITION | Centennial Therapeutics, LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20240409530-A1 | Disubstituted Pyrimidine Compounds for Ketohexokinase Inhibition | CENTENNIAL THERAPEUTICS, LLC | 2024-12-12 | — | — | US | disclosed |
| US-12139467-B2 | Methods of synthesizing cannabielsoin and analogs thereof | CANOPY GROWTH CORPORATION (CA) | 2024-11-12 | — | — | US | disclosed |
| WO-2024216034-A1 | DISUBSTITUTED PYRIMIDINE COMPOUNDS FOR KETOHEXOKINASE INHIBITION | CENTENNIAL THERAPEUTICS, LLC (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-117843707-A | Preparation method of brassinolide intermediate | 上海皓元医药股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| EP-4188915-A1 | METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF | Canopy Growth Corporation (CA) | 2023-06-07 | — | — | EP | disclosed |
| US-20230146330-A1 | METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF | JGB COLLATERAL LLC | 2023-05-11 | — | — | US | disclosed |
| CN-111518154-B | Preparation method of 24-epibrassinol intermediate (22E, 24R) -3 alpha, 5-ring-5 alpha-ergosta-7, 22-diene-6-ketone | 郑州郑氏化工产品有限公司 | 2021-03-19 | — | — | CN | disclosed |
| CN-111518154-B | Preparation method of 24-epibrassinol intermediate (22E, 24R) -3 alpha, 5-ring-5 alpha-ergosta-7, 22-diene-6-ketone | 郑州郑氏化工产品有限公司 | 2021-03-19 | — | — | CN | disclosed |
| CN-111518154-A | Preparation method of 24-epibrassinol intermediate | 郑州郑氏化工产品有限公司 | 2020-08-11 | — | — | CN | disclosed |
| CN-111518154-A | Preparation method of 24-epibrassinol intermediate | 郑州郑氏化工产品有限公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-0985664-B1 | Method of producing pyrrolidine derivatives | TORAY FINECHEMICALS CO LTD (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-6479668-B1 | Method of producing pyrrolidine derivatives | TORAY INDUSTRIES, INC. (JP) | 2002-11-12 | — | — | US | disclosed |
| EP-0985664-A2 | Method of producing pyrrolidine derivatives | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409530-A1 | Disubstituted Pyrimidine Compounds for Ketohexokinase Inhibition | KHK, GCK, HK1 | SLC22A1 1102/4885RECQL 2097/4885TSHR 3479/4885 |
| US-20230146330-A1 | METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF | CNR2, CNR1, CBR3 | SLC22A1 4857/4885RECQL 3001/4885TSHR 4278/4885 |
| US-12139467-B2 | Methods of synthesizing cannabielsoin and analogs thereof | CNR2, CNR1, CBR3 | SLC22A1 4857/4885RECQL 3001/4885TSHR 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.